ASF Standards · Telemedicine · Standard 5
Standard 5 — Prescribing & Controlled Substance Management
Criteria in this standard
5.1 — Controlled Substance Prescribing Genuinely Tracks Current National Regulatory Status
5.2 — Every Controlled Substance Prescription Is Genuinely for a Legitimate Medical Purpose
5.3 — Sub-National Controlled Substance Requirements Are Verified Alongside National Rules
5.4 — Prescribing Restricted Stimulants to Minors Follows Any Narrow Exception Precisely
5.5 — A Provider's Controlled Substance Prescribing Authorization Is Verified and Current
5.2 — Every Controlled Substance Prescription Is Genuinely for a Legitimate Medical Purpose
5.3 — Sub-National Controlled Substance Requirements Are Verified Alongside National Rules
5.4 — Prescribing Restricted Stimulants to Minors Follows Any Narrow Exception Precisely
5.5 — A Provider's Controlled Substance Prescribing Authorization Is Verified and Current
5.1
Controlled Substance Prescribing Genuinely Tracks Current National Regulatory Status
Non-Negotiable
Controlled substance prescribing practice genuinely reflects the current regulatory status in the relevant jurisdiction — not a fixed assumption based on a rule that was true previously, given that telemedicine prescribing rules for controlled substances remain genuinely evolving in many countries.
In plain terms: The service knows the current rules for prescribing controlled substances by telemedicine in every jurisdiction it serves — and follows them, updating when they change.
| Facility category | Crisis | Transition | Small | Standard |
|---|---|---|---|---|
| Applicability | Full | Full | Full | Full |
Why this matters
Controlled substance prescribing by telemedicine is heavily regulated and the rules change: pandemic flexibilities were introduced and then withdrawn or extended; some jurisdictions require an in-person visit before or within a period of remote prescribing; some prohibit remote prescribing of certain schedules entirely. A service that follows last year's rules is breaking this year's law. The compliance lead must track the current status in every jurisdiction, document it, brief prescribers, and update the prescribing protocol when rules change. Ignorance is not a defence.
What good looks like
- The service genuinely knows the current, specific requirements in this jurisdiction.
- A real, active monitoring process tracks regulatory status changes.
- Providers genuinely understand any current flexibility as provisional, not permanent.
Common failure modes
- The service assumes current flexibility is a permanent, settled rule.
- No active monitoring process exists for regulatory status changes.
- Providers are unaware this flexibility could lapse or change.
Worked example
In practice
A telemedicine service prescribing controlled substances for ADHD and anxiety across several jurisdictions.
BeforePrescribers followed the flexibilities introduced during the pandemic, unaware that some had expired. In two jurisdictions, an in-person examination had become required before remote controlled prescribing; the service had not adapted. Hundreds of prescriptions were non-compliant.
ActionThe compliance lead built a regulatory register: for each jurisdiction, the current controlled substance telemedicine rules with source and date; a quarterly review against regulator announcements; a prescriber briefing on any change within a week; prescribing protocol updated accordingly. Where in-person examination is now required, a network of local partners provides it. Non-compliant historical prescribing was reviewed with counsel.
AfterThe Monitor reviewed the register with sources, three quarterly reviews, two change briefings, and the updated protocol. Verified.
If you are starting from zero — do this first
- For each jurisdiction, write down the current rule for remote controlled substance prescribing, with the source.
- Check whether any pandemic flexibility you rely on has expired.
- Brief prescribers.
- Review quarterly.
The most common mistake: Still prescribing under pandemic-era flexibilities that have quietly expired.
Self-assessment questions
1. Does the service genuinely know the current telemedicine prescribing requirements in this jurisdiction? — Real, current knowledge, not a general assumption they remain fixed.
Evidence: Current regulatory status documentation
Evidence: Current regulatory status documentation
2. Is there a specific process for monitoring and responding to a change in this regulatory status? — A real, active monitoring process, not passive reliance on unchanged practice.
Evidence: Regulatory monitoring process
Evidence: Regulatory monitoring process
3. Are providers genuinely aware that any current flexibility is provisional, not permanent? — Real, accurate understanding, not an assumption of permanence.
Evidence: Provider awareness of temporary status
Evidence: Provider awareness of temporary status
Common reasons for a PARTIAL answer
- Leadership is aware of the current temporary status but this awareness hasn't been specifically communicated to prescribing providers. — Every provider actually prescribing controlled substances needs the same genuine, current awareness.
- Monitoring happens informally but isn't assigned as a specific, accountable responsibility. — A specific, accountable monitoring responsibility is more reliable than informal, diffuse awareness.
- The service tracks the current regulatory status but hasn't built a specific contingency plan for if a flexibility lapses without renewal.
Implementation plan
| When | What |
|---|---|
| Week 1 | Confirm the service's current, specific knowledge of the applicable requirements' status in this jurisdiction. |
| Week 2 | Assign specific, accountable responsibility for monitoring regulatory status changes. |
| Week 3 | Communicate current temporary status clearly to all prescribing providers. |
| Ongoing | Build a contingency plan for a potential lapse in the temporary extension. |
How the Monitor verifies this
| Method | What | Detail |
|---|---|---|
| DOCUMENT | Current status review | Reviews documentation confirming the service's specific, current knowledge of the current requirements' status. |
| DOCUMENT | Monitoring process review | Reviews the specific process for monitoring and responding to regulatory status changes. |
| ASK | Provider awareness interview | Asks a provider whether they understand the current prescribing flexibility as temporary, not permanent. |
Supervisor tips
- Ask a provider directly what the current status of the relevant telemedicine prescribing flexibility is in this jurisdiction. — A specific, accurate answer reveals genuine, current awareness, not an assumption of permanence.
- Ask who is specifically responsible for monitoring this regulatory status. — A specific, confident answer reveals a real, accountable process, not diffuse or assumed awareness.
Evidence base
[21] Telemedicine prescribing regulations for controlled substances remain an actively evolving area of law in numerous countries, with the underlying international framework under the Single Convention on Narcotic Drugs (1961, as amended) requiring national implementation that can itself change, making active tracking of current, jurisdiction-specific requirements a genuine, ongoing necessity.
ASF training courses on GMJ Academy →
Foundation courses A-00 to A-03 are live. Criterion-specific modules are being developed and will link here when published.
5.2
Every Controlled Substance Prescription Is Genuinely for a Legitimate Medical Purpose
Non-Negotiable
Every controlled substance prescription issued via telemedicine is genuinely, verifiably issued for a legitimate medical purpose by a provider acting within the usual course of professional practice — the same underlying requirement that applies whether the evaluation was conducted in person or remotely, not a standard that relaxes because the visit happened to be virtual.
In plain terms: Every controlled substance prescription issued remotely is for a genuine, documented medical purpose — a real diagnosis, a real assessment, a real record — not issued on request.
| Facility category | Crisis | Transition | Small | Standard |
|---|---|---|---|---|
| Applicability | Full | Full | Full | Full |
Why this matters
Telemedicine controlled prescribing has been abused: services that issue stimulant or benzodiazepine prescriptions after a five-minute video call with no examination, no records, no diagnosis. Regulators and prosecutors treat this as drug dealing. Legitimate purpose means: a documented diagnosis meeting recognised criteria; an assessment adequate to support it; a treatment plan; monitoring; and records that would satisfy an auditor. The service should be able to justify every controlled prescription from the record alone. If it cannot, the prescription was not legitimate.
What good looks like
- Every prescription has genuine, documented evidence of legitimate medical purpose.
- The same rigor applies to remote prescribing as would apply in person.
- A real, active process reviews prescribing patterns for potential concern.
Common failure modes
- Prescriptions lack genuine, specific documentation of medical necessity.
- Remote prescribing is treated with less rigor than in-person practice.
- No process reviews prescribing patterns for potential inadequate verification.
Worked example
In practice
A telemedicine service prescribing stimulants for adult ADHD.
BeforePrescriptions were issued after a single 20-minute video consultation using a self-report questionnaire. No collateral history, no prior records, no structured diagnostic assessment. An audit found diagnoses supported by adequate documentation in fewer than half of cases.
ActionA controlled prescribing protocol was written: for ADHD, a structured diagnostic assessment (validated rating scales, developmental history, collateral information where possible, screening for substance use and other conditions) over at least two sessions before any prescription; a documented treatment plan; prescription monitoring programme check; follow-up at defined intervals; the record must independently support the diagnosis. A monthly audit of 20 controlled prescriptions checks documentation adequacy.
AfterThe Monitor reviewed the protocol and three monthly audits: documentation adequate in 96% of cases; inadequate cases reviewed with the prescriber. Verified.
If you are starting from zero — do this first
- Pull 20 controlled substance prescriptions. Could an auditor justify each from the record alone?
- Write a diagnostic assessment protocol per condition.
- Require it before any controlled prescription.
- Audit monthly.
The most common mistake: Prescribing after one video call and a questionnaire — that is not an assessment.
Self-assessment questions
1. Is every controlled substance prescription genuinely, verifiably issued for documented medical necessity? — Real, verifiable documentation, not a prescription lacking genuine clinical justification.
Evidence: Prescription medical necessity documentation
Evidence: Prescription medical necessity documentation
2. Is this standard applied with the same rigor remotely as it would be in person? — Real, equivalent rigor, not a relaxed standard for remote convenience.
Evidence: N/A — tested directly
Evidence: N/A — tested directly
3. Is there an active process for identifying a prescribing pattern suggesting inadequate verification? — A real, active review process, not passive trust alone.
Evidence: Prescribing pattern review process
Evidence: Prescribing pattern review process
Common reasons for a PARTIAL answer
- Documentation is thorough for new prescriptions but less rigorous for ongoing refills of existing prescriptions. — Genuine, continued medical necessity deserves the same documentation rigor at refill as at initial prescribing.
- Rigor is generally equivalent but providers report feeling more rushed during high-volume remote scheduling. — Genuine rigor shouldn't erode under scheduling pressure, remote or in-person.
- A pattern review process exists but hasn't identified or addressed any real concern to date.
Implementation plan
| When | What |
|---|---|
| Week 1 | Review current prescription documentation for genuine, specific medical necessity evidence. |
| Week 2 | Reinforce documentation standards for refills, not only initial prescriptions. |
| Week 3 | Establish a genuine pattern review process for prescribing across the service. |
| Ongoing | Address any scheduling pressure that risks eroding prescribing rigor. |
How the Monitor verifies this
| Method | What | Detail |
|---|---|---|
| DOCUMENT | Medical necessity documentation review | Reviews prescription records for genuine, specific documentation of legitimate medical purpose. |
| OBSERVE | Rigor equivalence observation | Observes remote prescribing consultations for genuine rigor equivalent to in-person practice. |
| DOCUMENT | Pattern review process review | Reviews the process for identifying prescribing patterns suggesting inadequate verification. |
Supervisor tips
- Ask to see the actual documented medical necessity for a specific, real controlled substance prescription. — A real, specific example reveals genuine documentation practice, not an assumption of adequacy.
- Ask how the service would identify a concerning prescribing pattern if one existed. — A specific, confident answer reveals a genuine, real process, not passive trust alone.
Evidence base
[22] The Single Convention on Narcotic Drugs (1961, as amended), ratified by 186 countries, establishes that the production, distribution, and use of controlled substances must be limited exclusively to medical and scientific purposes, a principle applying identically whether a prescription is issued in person or via telemedicine.
ASF training courses on GMJ Academy →
Foundation courses A-00 to A-03 are live. Criterion-specific modules are being developed and will link here when published.
5.3
Sub-National Controlled Substance Requirements Are Verified Alongside National Rules
Non-Negotiable
Sub-national or regional controlled substance prescribing requirements — where the relevant country has a federal, provincial, or similarly devolved governance structure — are genuinely verified alongside national-level rules, not assumed covered by national compliance alone, given some regions impose their own, additional requirements beyond what national law requires.
In plain terms: Where a country has both national and regional controlled-substance rules, the service checks both for the patient's location — the stricter one applies.
| Facility category | Crisis | Transition | Small | Standard |
|---|---|---|---|---|
| Applicability | Full | Full | Adapted | Full |
Why this matters
Federal systems have layered rules: the national law sets a floor; states, provinces, or regions add their own — a prescription monitoring programme check, a cap on quantity, an in-person requirement, a prohibition on certain drugs. A service compliant with national law and unaware of the regional rule is breaking the law in that region. The regulatory register (5.1) must include the sub-national layer for every region served, and prescribers must check both before every controlled prescription. The stricter rule always governs.
What good looks like
- Sub-national requirements are genuinely, specifically verified for each relevant region.
- Verification is genuinely current, reflecting recent regional regulatory updates.
- The more restrictive applicable standard is genuinely followed when regional and national rules differ.
Common failure modes
- Only national requirements are tracked, with sub-national rules assumed covered.
- Verification is outdated, missing recent regional regulatory changes.
- The more permissive national standard is followed even where a region imposes a stricter requirement.
Worked example
In practice
A telemedicine service in a federal country prescribing controlled substances across 15 regions.
BeforeThe service followed national rules. It was unaware that several regions required a prescription monitoring programme query before any controlled prescription, and that one region prohibited remote prescribing of a schedule the service used routinely. Prescriptions in those regions were non-compliant.
ActionThe regulatory register was extended to include each region's controlled substance rules: PMP query requirements, quantity limits, in-person requirements, prohibited schedules. The prescribing system displays the applicable regional rules when the patient's location is entered. Prescribers must confirm the regional check. PMP queries are logged per prescription.
AfterThe Monitor reviewed the extended register, the prescribing system's regional rule display, and 30 prescriptions with regional compliance and PMP queries documented. Verified.
If you are starting from zero — do this first
- For each region you serve, find its controlled substance prescribing rules — not just the national ones.
- Add them to your register.
- Make the prescriber confirm the regional check before every controlled prescription.
- Log PMP queries.
The most common mistake: Assuming national compliance is enough in a federal system — the region may have stricter rules.
Self-assessment questions
1. Are sub-national requirements genuinely verified for each region, where such authority exists? — Real, per-region verification, not an assumption national compliance alone is sufficient.
Evidence: Sub-national requirement verification record
Evidence: Sub-national requirement verification record
2. Is this verification genuinely current, reflecting each region's recent updates? — Real, current verification, not outdated regional understanding.
Evidence: N/A — tested directly
Evidence: N/A — tested directly
3. When a region's requirement is stricter than the national baseline, is the stricter standard actually followed? — Real adherence to the more restrictive standard, not the more permissive one.
Evidence: Restrictive-standard adherence documentation
Evidence: Restrictive-standard adherence documentation
Common reasons for a PARTIAL answer
- Sub-national verification happens for regions with the highest patient volume but not for less frequent regions. — Every region where a patient is genuinely located carries the same real requirement, regardless of patient volume.
- Verification was thorough at initial setup but hasn't been reconfirmed as regional regulations have since evolved. — Regional requirements genuinely change, and verification should reflect current, not historical, regulation.
- Awareness of a stricter regional requirement exists but isn't consistently, practically applied in actual prescribing.
Implementation plan
| When | What |
|---|---|
| Week 1 | Review current practice for genuine sub-national verification alongside national compliance. |
| Week 2 | Establish specific verification for every region where patients are genuinely located, where such regional authority exists. |
| Week 3 | Build a process for identifying and applying the more restrictive standard where regional and national rules differ. |
| Ongoing | Reconfirm sub-national requirements as regulations evolve. |
How the Monitor verifies this
| Method | What | Detail |
|---|---|---|
| DOCUMENT | Sub-national verification review | Reviews documentation of genuine, specific regional-level requirement verification. |
| DOCUMENT | Currency review | Reviews whether regional verification reflects current, recent regulatory updates. |
| DOCUMENT | Restrictive-standard adherence review | Reviews evidence that the more restrictive applicable standard, regional or national, is genuinely followed. |
Supervisor tips
- Ask how the service verifies controlled substance requirements for a specific, less common patient region. — A specific, confident answer reveals genuine, comprehensive verification, not coverage limited to high-volume regions.
- Ask for a real example of a regional requirement stricter than the national baseline and how it's actually applied. — A real, specific example reveals whether the more restrictive standard genuinely governs practice.
Evidence base
[23] In countries with federal, provincial, or similarly devolved governance structures, sub-national controlled substance telemedicine prescribing rules can apply independently of and in addition to national requirements, with some regions imposing distinct exceptions or conditions beyond the national baseline.
ASF training courses on GMJ Academy →
Foundation courses A-00 to A-03 are live. Criterion-specific modules are being developed and will link here when published.
5.4
Prescribing Restricted Stimulants to Minors Follows Any Narrow Exception Precisely
Non-Negotiable
Where a narrow exception exists in this jurisdiction permitting a restricted stimulant medication to be prescribed to a minor without a prior in-person evaluation, the service genuinely follows that exception's specific, actual conditions — such as real-time interactive audio-visual technology and prior written guardian consent — not treated as a general allowance applicable without these specific conditions genuinely met; where no such exception exists here, the standard in-person evaluation requirement applies without exception.
In plain terms: If the jurisdiction allows a narrow exception for prescribing a restricted stimulant to a minor by telemedicine, the service follows the exception's exact conditions — every one — or does not prescribe.
| Facility category | Crisis | Transition | Small | Standard |
|---|---|---|---|---|
| Applicability | Full | Full | Adapted | Full |
Why this matters
Some jurisdictions prohibit remote prescribing of stimulants to minors outright; some allow it only under specific conditions — an existing in-person relationship, a prior in-person examination within a period, a specific diagnosis, a specific provider type, parental presence during the session. An exception is narrow by design. A service that meets some conditions and not others is outside the exception. The service must know the exact conditions, document compliance with each for every prescription, and decline when any is unmet. When in doubt, the answer is in-person referral.
What good looks like
- Real-time, interactive audio-visual technology is genuinely used for every such prescription.
- Prior written parental or guardian consent is genuinely obtained and documented.
- The exception is applied only within its genuine, narrow scope.
Common failure modes
- A lower-fidelity or asynchronous technology modality is used instead of real-time audio-visual.
- Consent is verbal, obtained after the fact, or not genuinely documented.
- The exception is applied more broadly than its actual, narrow scope permits.
Worked example
In practice
A telemedicine paediatric mental health service.
BeforeStimulants were prescribed to minors remotely on the assumption that a general telemedicine allowance covered it. The jurisdiction permitted this only where an in-person examination had occurred within the previous 12 months and a parent was present. Neither condition was checked.
ActionThe exception's conditions were extracted from the regulation and turned into a checklist that must be completed for every stimulant prescription to a minor: prior in-person examination date and provider; parent or guardian present and identified; diagnosis meeting criteria; prescriber type permitted. Any unmet condition blocks the prescription and generates an in-person referral. The checklist is part of the prescription record.
AfterThe Monitor reviewed the extracted conditions, the checklist, and 20 minor stimulant prescriptions with complete checklists; 6 showed prescriptions declined for unmet conditions with referral. Verified.
If you are starting from zero — do this first
- Find the exact regulation for remote stimulant prescribing to minors in your jurisdiction.
- List every condition of any exception.
- Build a checklist requiring each.
- Decline when any is unmet.
The most common mistake: Meeting most of the exception's conditions — an exception with one unmet condition is no exception.
Self-assessment questions
1. Is real-time, interactive audio-visual technology genuinely used, not a lower-fidelity alternative? — Real, specific technology meeting the exact requirement, not a lesser substitute.
Evidence: Technology modality documentation
Evidence: Technology modality documentation
2. Is prior written parental or guardian consent genuinely obtained and documented? — Real, prior, written consent, not verbal or after-the-fact agreement.
Evidence: Written parental consent documentation
Evidence: Written parental consent documentation
3. Is this exception applied only to the specific medication and population it actually covers? — Genuine, narrow application, not extended beyond the exception's actual scope.
Evidence: N/A — tested directly
Evidence: N/A — tested directly
Common reasons for a PARTIAL answer
- Consent is obtained but not consistently documented as specifically written and prior to the prescription. — The exception's specific requirement is prior written consent, and documentation should genuinely reflect this exact standard.
- Technology modality is generally real-time but isn't specifically verified as meeting the interactive audio-visual requirement. — Genuine verification of the specific technology standard matters as much as general real-time capability.
- The exception is correctly applied for restricted stimulants but staff aren't fully clear it doesn't extend to other medication classes.
Implementation plan
| When | What |
|---|---|
| Week 1 | Review current practice for genuine adherence to this exception's specific requirements. |
| Week 2 | Confirm technology modality and consent documentation specifically meet the exact exception standard. |
| Week 3 | Train providers on the exception's genuine, narrow scope, not broader application. |
| Ongoing | Audit compliance for every use of this specific exception. |
How the Monitor verifies this
| Method | What | Detail |
|---|---|---|
| DOCUMENT | Technology modality review | Reviews records confirming real-time, interactive audio-visual technology was genuinely used. |
| DOCUMENT | Written consent review | Reviews documentation of genuine, prior written parental or guardian consent. |
| DOCUMENT | Scope adherence review | Reviews whether this exception is applied only within its actual, narrow scope. |
Supervisor tips
- Ask to see the actual, written parental consent document for a real, recent case using this exception. — A real, specific document reveals genuine compliance, not an assumption consent was obtained appropriately.
- Ask a provider to describe exactly which medications and patients this exception genuinely applies to. — A specific, accurate answer reveals genuine understanding of the exception's actual, narrow scope.
Evidence base
[24] Some jurisdictions permit a narrow exception for prescribing certain restricted stimulant medications to minors using real-time, interactive audio-visual technology and prior written guardian consent, in place of the standard in-person evaluation requirement; where no such exception exists in a given jurisdiction, the standard requirement applies without exception.
ASF training courses on GMJ Academy →
Foundation courses A-00 to A-03 are live. Criterion-specific modules are being developed and will link here when published.
5.5
A Provider's Controlled Substance Prescribing Authorization Is Verified and Current
Core
Every prescribing provider's controlled substance prescribing authorization — issued by the relevant competent national authority — is genuinely verified as current and in good standing, not assumed valid from a historical check, and reconfirmed on a genuine, regular schedule rather than left unexamined until a problem surfaces.
In plain terms: Every prescriber's authority to prescribe controlled substances — the registration or licence issued by the competent authority — is verified with that authority and is current, not assumed from their medical licence.
| Facility category | Crisis | Transition | Small | Standard |
|---|---|---|---|---|
| Applicability | Full | Full | Full | Full |
Why this matters
A medical licence does not by itself authorise controlled substance prescribing. In many jurisdictions, a separate registration (DEA in the US, equivalents elsewhere) is required, expires, can be suspended, and must be verified directly. A prescriber whose registration has lapsed is issuing invalid prescriptions — which pharmacies may reject and regulators may prosecute. The service must verify each prescriber's registration with the issuing authority at hire and at each renewal, track expiry dates, and suspend controlled prescribing when a registration lapses.
What good looks like
- Every provider's authorization is genuinely, currently verified.
- Verification is genuinely reconfirmed on a regular, periodic schedule.
- A real, enforced process prevents prescribing when a registration issue is identified.
Common failure modes
- Registration status is assumed valid from a past, historical check.
- Verification is never reconfirmed after initial onboarding.
- Prescribing continues despite an identified registration issue.
Worked example
In practice
A telemedicine service with 12 prescribers of controlled substances.
BeforeControlled substance registrations were assumed from the prescribers' CVs. Two prescribers' registrations had expired without renewal; they had continued prescribing. A pharmacy rejected a prescription, which was how the service found out.
ActionEach prescriber's controlled substance registration was verified with the issuing authority and recorded with expiry date. A 90-day renewal reminder is sent to the prescriber and the compliance lead. Prescribing privileges for controlled substances are suspended automatically in the system when a registration expires. Annual re-verification with the authority.
AfterThe Monitor reviewed the registration record for all prescribers with verification evidence and expiry dates, and the system configuration blocking prescribing on expiry. Verified.
If you are starting from zero — do this first
- For each prescriber, verify their controlled substance registration with the issuing authority.
- Record the expiry date.
- Set 90-day reminders.
- Configure the system to block controlled prescribing on expiry.
The most common mistake: Assuming a doctor can prescribe controlled substances because they are a doctor.
Self-assessment questions
1. Is every prescribing provider's controlled substance authorization genuinely verified as current, not assumed from a historical check? — Real, current verification, not reliance on a past check assumed to remain valid.
Evidence: Prescribing authorization verification record
Evidence: Prescribing authorization verification record
2. Is this verification genuinely reconfirmed on a regular schedule, not left unexamined indefinitely? — Real, periodic reconfirmation, not a one-time check treated as permanently sufficient.
Evidence: Periodic reconfirmation schedule
Evidence: Periodic reconfirmation schedule
3. Is there a specific process preventing prescribing if an authorization issue is genuinely identified? — A real, enforced block, not prescribing continuing despite a known authorization concern.
Evidence: Authorization issue prevention process
Evidence: Authorization issue prevention process
Common reasons for a PARTIAL answer
- Verification happens for full-time prescribing providers but less consistently for occasional or covering providers. — Every provider actually prescribing controlled substances carries the same real requirement for current, verified registration.
- Verification is reconfirmed periodically but the interval is long enough that a genuine lapse could go uncaught for a meaningful time. — A genuinely protective interval catches a lapse before it affects a meaningful number of prescriptions.
- A prevention process exists but hasn't been specifically tested against a real, identified registration issue.
Implementation plan
| When | What |
|---|---|
| Week 1 | Review current authorization verification practice for genuine currency and consistency. |
| Week 2 | Establish a regular, periodic reconfirmation schedule covering all prescribing providers. |
| Week 3 | Build a specific, enforced prevention process for identified registration issues. |
| Ongoing | Extend verification consistently to occasional and covering providers. |
How the Monitor verifies this
| Method | What | Detail |
|---|---|---|
| DOCUMENT | Verification record review | Reviews evidence of genuine, current authorization verification for every prescriber. |
| DOCUMENT | Reconfirmation schedule review | Reviews whether verification is genuinely, periodically reconfirmed. |
| DOCUMENT | Prevention process review | Reviews the specific process preventing prescribing when a registration issue is identified. |
Supervisor tips
- Ask to see the actual, current authorization verification for a specific prescribing provider. — A real, specific, current record reveals genuine verification, not an assumption of continued validity.
- Ask what would happen if a provider's registration were found to have lapsed. — A specific, confident answer reveals a genuine, enforced prevention process.
Evidence base
[25] Under the international framework established by the Single Convention on Narcotic Drugs, each country designates a competent national authority responsible for controlled substance prescribing authorization, with this authorization status forming the foundational basis for lawful prescribing, requiring genuine, periodic verification distinct from a one-time historical check assumed to remain accurate indefinitely.
ASF training courses on GMJ Academy →
Foundation courses A-00 to A-03 are live. Criterion-specific modules are being developed and will link here when published.